Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART

Antiviral Therapy

Volumn 8, Issue 1, 2003, Pages 17-26

  Chang, Linda ^a,b   Ernst, Thomas ^a,b   Witt, Mallory D ^b   Ames, Nina ^b   Walot, Irwin ^b   Jovicich, Jorge ^b   DeSilva, Menaka ^b   Trivedi, Neha ^b   Speck, Oliver ^b   Miller, Eric N ^b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHOLINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; INOSITOL; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BRAIN INJURY; BRAIN LEVEL; BRAIN REGION; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SERODIAGNOSIS; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAIN; CD4 LYMPHOCYTE COUNT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROPSYCHOLOGICAL TESTS; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD;

EID: 12244255096     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz M & Ho DD. Decay characteristics of HIV-1-infected compartments during combination therapy [see comments]. Nature 1997; 387(6629):188-191.
2. Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, Rickenbach M, Malinverni R, Vernazza P & Battegay M. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV cohort study. British Medical Journal 1997; 315:1194-1199.
3. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ & Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators [see comments]. New England Journal of Medicine 1998; 338(13):853-860.
4. McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M & Lanier ER. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Annals of Neurology 1997; 42(5):689-698.
5. Stingele K, Haas J, Zimmermann T, Stingele R, Hubsch-Muller C, Freitag M, Storch-Hagenlocher B, Hartmann M & Wildemann B. Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy. Neurology 2001; 56(3):355-361.
6. Cinque P, Presi S, Bestetti A, Pierotti C, Racca S, Boeri E, Morelli P, Carrera P, Ferrari M & Lazzarin A. Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. AIDS Research in Human Retroviruses 2001; 17(5):377-383.
7. Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA & Group HNRC. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Annals of Neurology 1997; 42(5):679-688.
8. Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA & Gonzalez RG. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology 1996; 46:783-788.
9. Chang L, Ernst T, Leonido-Yee M, Walot I & Singer E. Cerebral metabolite abnormalities correlate with clinical severity of HIV-cognitive motor complex. Neurology 1999; 52(1):100-108.
10. Sacktor N, Lyles R, Skolasky R, Anderson D, McArthur J, McFarlane G, Selnes O, Becker J, Cohen B, Wesch J & Miller E. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive omosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 1999; 52(8):1640-1647.
11. Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I & Miller EN. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 1999; 53:782-789.
12. Stankoff B, Tourbah A, Suarez S, Turell E, Stievenart J, Payan C, Coutellier A, Herson S, Baril L, Bricaire F, Calvez V, Cabanis E, Lacomblez L & Lubetzki C. Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology 2001; 56(1):112-115.
13. Janssen RS, Cornblath DR, Epstein LG, Foa RP, McArthur JC & Price RW. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991; 41:778-785.
14. Karnofsky DA & Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. 1949; pp. 199-205. Edited by C MacLeod. New York: Columbia University Press.
15. Power C & Johnson RT. HIV-1 Associated Dementia: Clinical Features and Pathogenesis. Canadian Journal of Neurological Sciences 1995; 22:92-100.
16. Price R & Brew B. The AIDS Dementia complex. The Journal of Infectious Diseases 1988; 158:1079-1083.
17. KlØve H. Clinical neuropsychology. In The Medical Clinics of North America. 1964; pp. 110-125. Edited by F Forster. New York: WB Saunders.
18. Anonymous. Army Individual Test Battery: manual of directions and scoring. Washington, DC: War Department, Adjutant General's Office; 1944.
19. Smith A. Symbol Digit Modalities Test: Western Psychological Services. 1982.
20. Rey A. L'examen psycholoqiue dans les cas d'encephalopathie traumatique. Archives of Psychology 1941; 28:286-340.
21. Stroop J. Studies of interference in serial verbal reaction. Journal of Experimental Psychology 1935; 18:643-662.
22. Radloff LL. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measures 1977; 1:385-401.
23. Blair J & Spreen O. The New Adult Reading Test - Revised Manual. 1989. Victoria, Canada: University of Victoria.
24. Miller EN. California Computerized Assessment Package. 1990. Edited by Custom. Los Angeles: Norland Software.
25. Uchiyama C, D'Elia L, Dellinger A, Selnes O, Becker J, Wesch J, Chen B, Satz P, Van Gorp W, Miller E & the Multicenter AIDS Cohort Study. Longitudinal comparison of alternate versions of the symbol digit modalities test: issues of form comparability and moderating demographic variables. The Clinical Neuropsychologist 1994; 8:209-218.
26. Uchiyama C, D'Elia L, Dellinger A, Becker J, Selnes O, Wesch J, Chen B, Satz P, Van Gorp W, Miller E & the Multicenter AIDS Cohort Study. Alternative forms of the auditory-verbal learning test: issues of test comparability, longitudinal reliability, and moderating demographic variables. Archives of Clinical Neuropsychology 1995; 10:133-145.
27. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Annals of the New York Academy of Sciences 1987; 508:333-348.
28. Ernst T & Chang L. Elimination of artifacts in short echo time 1H MR spectroscopy of the frontal lobe. Magnetic Resonance in Medicine 1996; 36:462-468.
29. Kreis R, Ernst T & Ross BD. Absolute quantitation of water and metabolites in the human brain. II: metabolite concentrations. Journal of Magnetic Resonance 1993; B102:9-19.
30. Ernst T, Kreis R & Ross BD. Absolute quantitation of water and metabolites in the human brain. I: compartments and water. Journal of Magnetic Resonance 1993; B102:1-8.
31. Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986; 73(3):751-754.
32. Gisslen M, Svennerholm B, Norkrans G, Franzen C, Sall C, Svensson R, Oberg S & Hagberg L. Cerebrospinal fluid and plasma viral load in HIV-1 infected patients with various anti-retroviral treatment regimens. Scandinavian Journal of Infectious Diseases 2000; 32(4):365-369.
33. Laubenberger J, Haussinger D, Bayer S, Thielemann S, Schneider B, Mundinger A, Hennig J & Langer M. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 1996; 199:805-810.
34. Lopez-Villegas D, Lenkinski RE & Frank I. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proceedings of the National Academy of Sciences, USA 1997; 94(18):9854-9859.
35. von Giesen H, Wittsack H, Wenserski F, Koller H & Arendt G. Basal ganglia metabolite abnormalities in minor motor disorder associated with human immunodeficiency virus type 1. Archives of Neurology 2001; 58(8):1281-1286.
36. Brand A, Richter-Landsberg C & Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Developmental Neurosciences 1993; 15:289-298.
37. Wilkinson I, Paley M, Miszkiel K, Hall-Craggs M, Kendall B, Chinn R & MJ H. Cerebral volumes and spectroscopic proton metabolites on MR: is sex important? Magnetic Resonance Imaging 1997; 15(2):243-248.
38. Pouwels P & Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magnetic Resonance in Medicine 1998; 39(1):53-60.
39. Komoroski R, Heimberg C, Cardwell D & Karson C. Effects of gender and region on proton MRS of normal human brain. Magnetic Resonance Imaging 1999; 17(3):427-433.
40. Gendelman H, Zheng J, Coulter C, Ghorpade A, Che M, Thylin M, Rubocki R, Persidsky Y, Hahn F, Reinhard JJ & Swindells S. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. Journal of Infectious Disease 1998; 178(4):1000-1007.
41. Lezak MD. Neuropsychological Assessment. Third Edition 1995. New York: Oxford University Press.
42. Sacktor N, Tarwater P, Skolasky M, McArthur J, Selnes O, Becker J, Cohen B, Miller E & the Multicenter AIDS Cohort Study. CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing. Neurology 2001; 57(3):542-544.
43. Sacktor N, Skolasky R, Tarwater P, McArthur J, Selnes O, Becker J, Cohen B & Miller E. The relationship between viral load response to highly active antiretroviral therapy and psychomotor speed performance in HIV+ homosexual men. Journal of Neurovirology 2002; 8(Suppl. 1):15.
44. Schmitt F, Bigley J, McKinnis R, Logue P, Evans R & Drucker J. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine 1988; 319(24):1573-1578.
45. Segal M. The blood-CSF barrier and the choroid plexus. In Introduction to the Blood-Brain Barrier. 1998; pp. 251-258. Edited by W Pardridge. Cambridge, UK: Cambridge University Press.
46. Berger J, Nath A, Greenberg R, Andersen A, Greene R, Rognar A & Avison M. Cerebrovascular changes in the basal ganglia with HIV dementia. Neurology 2000; 54(4):921-926.